Protillion Biosciences logo

Protillion Biosciences Funding & Investors

Burlingame, CA

Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. We have developed an entirely novel, powerful and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs.

protillion.com

Total Amount Raised: $18,000,000

Protillion Biosciences Funding Rounds

  • Series A

    $18,000,000

    Series A Investors

    Arch Venture Partners
    Illumina Ventures
Funding info provided by Diffbot.